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We have shown in the preceding paper that treatment  with cellular materi- 
als derived  from killed  mycobacteria  could,  under  the  proper  conditions,  in- 
crease the resistance of mice to subsequent infection with either Staphylococcus 
aureus  or Mycobacterium  fortuitum (1).  The results  now to be presented  dem- 
onstrate  that  the  same  crude  materials,  injected  under  other  experimental 
conditions, are capable of increasing the susceptibility of mice to various types 
of  bacteria,  and  indeed  can  convert  chronic  bacterial  infections  into  acute 
processes that may result in death. 
It must be emphasized that no information is available concerning the chem- 
ical nature  of the substances responsible for these biological effects. Nor is it 
known whether the same, or different, constituents of the bacterial preparations 
used,  were  responsible  for  the  protective  effects  reported  in  the  preceding 
paper,  and  for  the  enhancement  of infection  observed  in  the present  study. 
These aspects of the problem,  as well as the relevance of the phenomena ob- 
served  to  the  activation  of natural  infectious processes,  will  be  discussed  in 
subsequent publications. 
Materials and Methods 
The materials and techniques used in the present study were the same as those described 
in the preceding paper  (1). 
Experiments  were also carried out with a strain  of so called "atypical" mycobacterium 
listed in our collection as P17. This strain,  originally recovered from pulmonary  lesions in a 
human patient,  was kindly provided by Dr. Ernest H. Runyou of the Sunmount  Veterans 
Administration  Hospital,  Sunmount,  New  York.  It is pigmented,  grows rather  slowly in 
culture media, and does not cause progressive disease in guinea pigs (2). In our laboratory, 
this strain  has been found capable of multiplying  for a limited time in the liver and  lungs 
of albino mice. The bacilli disappear  progressively from these organs, although  small num- 
bers  of them persist  for several months. 
The llpopolysaccharide endotoxin used in some of the experiments reported here had been 
prepared  from  Serratia marcescens in  the  Dffco  Laboratories,  Detroit,  and  was  kindly 
supplied  by Mr.  H. W. Schoenlein. 
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1.  Enhancement of Heterologous Infections by S*multaneous Injection of Killed 
BCG Cells.- 
It was found in the experiments reported in the preceding paper that prior 
treatment  with  killed BCG  cells,  injected  by  the  intraperitoneal  route,  in- 
creased  the  resistance of mice  to subsequent  infection with Staph.  aureus  or 
Myco. fortuitum.  In contrast, it  will be presently shown  that  the intravenous 
TABLE I 
Enhancement of Staphylococcal Infection by Simultaneous Intravenous Injection of Killed BCG 
Cells 
Cumulative deaths st indicated days (d.) 
Killed BCG cells injected  Age of mice  after infection 
with staphylococci*  3d.  4d.  7d. 
rag.  ~ks. 
0 
0.1 
0 
0.1 
5 
9 
g~ 
(out of 16 mice) 
1  4  11 
5  8  14 
1  3  9 
14  16 
* Cell suspension heated at 90°C.  for 10 minutes,  injected intravenously with 0.05 ml. 
Staph. aureus (Giorgio). 
TABLE II 
Enhancement of Myco.  fortuitum infection by Subcutaneous Administration of Killed BCG Cdls 
Amount of killed BCG cells injected s.c.*  No. of deaths within 10 days after in~ection 
r&g. 
3 
0.3 
0.03 
Saline 
(out  of  5 mice) 
3 
3 
2 
0 
* Suspension  of phenol killed, acetone-washed  bacillary bodies injected subcutaneously 
in 0.3 ml. saline within 30 minutes after intravenous infection with 0.03 ml. Myco.  fortui~m. 
or subcutaneous injection of the same amount of BCG cells either at the same 
time as, or immediately after infection, markedly shortened  the survival time 
of the infected animals. 
Mice,  either 5 weeks or 9 weeks old, were infected by the intravenous route with 0.05 
ml. of an overnight culture of Staph. aureus (strain Giorgio). For half of each group the in- 
fective inoculum was mixed with 0.1 nag. of BCG cells killed by heating at 90°C. for 10 min- 
utes; the other animals received the staphylococci alone. In all cases, the inoculum was made 
up to 0.2 ml. with physiological saline. The survival times following infection are presented 
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As seen in Table I, mice receiving the infective inoculum of staphylococci in 
admixture with 0.1 rag. of killed BCG bacilli had a shorter survival time than 
mice infected with staphylococci alone. 
In the preceding experiment, enhancement of infection was achieved by intravenous in- 
jection of the active material. A  similar effect was produced in another experiment by ad- 
ministering via the subcutaneous route various amounts of BCG cells, killed by phenol and 
washed with acetone. An infective dose of 0.03 ml. of Myco. fortgitum had been injected 30 
minutes before this treatment (Table II). 
The results presented in Tables  I  and II demonstrate  that the infection- 
enhancing activity of killed BCG cells  could be  made evident by either the 
subcutaneous or the intravenous route of injection. As will appear from the 
results of other experiments presented in this paper, the intraperitoneal route 
was also effective. It will be seen, however, that the effect of the treatment on 
the course of infection varied greatly depending upon  the dose of bacterial 
product injected, and the time of injection. 
2.  Effect of Dose and Time of Injection of Mycobacterial Constituents on Their 
Ability to Enhance Staphylococcal Infections.-- 
Mice were vaccinated by the intraperitoneal route with methanol extract of BCG, or with 
cell residue left after methanol extraction. These materials were prepared from bacilli pre- 
viously washed with acetone and air dried  twice in succession, which were then heated in 
30 times their weight of boiling methanol, with constant stirring. The soluble fraction was 
separated  as  described  under  Materials  and  Methods  in  the  preceding  publication.  The 
bacillary residue was air-dried. For injection, the proper amounts of methanol extract or of 
residue were resuspended in 0.2 ml. of pyrogen-free saline. 
The animals were infected by the intravenous route 3  hours, 24 hours, or 7  days after 
injection of the BCG fraction. The survival times are recorded in Table III. 
As seen in Table  III,  the mice which had received methanol  extract, or 
bacterial residue, 3 hours before infection with staphylococci, died faster than 
infected animals treated with smaller  amounts of these bacillary constituents 
or with saline alone. When the staphylococci were injected 24 hours or 7 days 
after administration of the methanol extract or bacillary residue, the infection- 
enhancing effect of these materials was no longer apparent.  Furthermore, it 
can be surmised from the results of other experiments (as reported in the pre- 
ceding paper) that a protective effect would have been observed had infection 
taken place several weeks later. The smaller amounts of bacillary residue ex- 
erted no detectable infection-enhancing effect, even when administered just 
before the staphylococci, but on the other hand, the animals infected 24 hours 
or 7 days after receiving this material survived longer than the controls. 
3.  Activating Effect of Bacterial Products on Chronic Infections.- 
We have been able to establish in mice experimental infections with a chronic 
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aureus,  Myco.  tuberculosis,  Myco. fortuitum,  or "atypical" mycobacteria. The 
infections  so  produced  do  not  progress under  usual  circumstances,  and  the 
lesions may eventually heal. However, the animals continue for many months 
to  harbor  small  numbers  of  virulent  bacilli--in the  spleen  and  lungs  with 
Myco.  tuberculosis,  in the kidneys with Myco. fortuitum and Staph.  aureus.  As 
shown by the following results, this chronic type of infection could be rapidly 
brought into a  state of activity by administering to the infected animals small 
amounts of cellular constituents of Gram-negative bacilli or of mycobacteria. 
TABLE III 
Relation  of Dose and  Time of Administration on the Effect  of Constituents  of BCG Cells on 
Resistance of Mice to Stapkylocoecal Infection 
Materials  injected  Interval between  Cumulative  deaths at indicated 
treatment and  days (d.) after infection 
(i.p.)  infection  $ d.  4 d.  6 d.  8 d. 
mg. 
Methanol extract  5 
Bacterial residue  5 
"  "  1.5 
"  "  0.5 
Saline 
Methanol extract  5 
Bacterial residue  $ 
"  "  1.5 
"  "  O. 5 
Saline 
Methanol extract 
Bacterial residue 
~C  gg 
Saline 
3 hrs. before 
24 hrs. after 
5  7 days after 
5  ~c  ~c  cg 
1.5  ' ....  ' 
0.5  "  "  " 
gg  gg  lg 
(out of 8 mice) 
8 
6  8 
4  5  7  7 
1  5  6  8 
4  5  6  6 
6  6  7  7 
7  7  8 
5  5  7  7 
3  3  4  4 
8 
3  3  4  7 
2  3  4  4 
0  1  2  2 
0  2  4  6 
1  2  4  8 
Mice were  infected by the  intravenous  route with 0.002 ml. of a  7 day  old  culture 
of Myco. forl~it~m.  None of them died of the infection.  One  month  later they received 
by the intraperitoneal route either pertussis vaccine  (approximately 10  billion cells),  or 
killed cells of BCG (2 rag.), or physiological saline (0.2 ml.). Some of the animals were sac- 
Hficed S days after this treatment, others 9 days. The numbers of viable bacteria in their 
organs were determined by quantitative bacteriological techniques  (Table IV). 
As seen from the results presented in Table IV, injection of pertussis vaccine 
or of killed cells of BCG brought about an explosive multiplication of Myco. 
fortuitum  in the organs of mice which had been infected with a  small dose of 
this organism 1 month before. Injection of 50 gg. of lipopolysaccharide fraction 
prepared  from  Serra~ia  marcescens  caused  within  a  few  days  the  death  of 5 
out of 8  infected animals. Because  the enumeration of colonies in the organs RUSSELL W.  SCHAEDLER AND RENE  J.  DUBOS  723 
of the surviving  three animals  gave erratic results,  the bacteriological results 
of this particular test will not be presented. 
In another experiment similar in design, the interval between the establish- 
ment  of the  chronic infection  and  the injection  of bacterial  product was ex- 
tended to 3 months. Killed ceils of Myco. fortuitum were compared with killed 
cells of BCG with regard to their ability to activate the chronic infection. 
Mice  were  infected  by  the  intravenous  route with 0.005  ml.  of a  7  day old  culture 
of Myco.  fortuitum. None of them died of the infection. Three months later they received by 
the intraperitoneal  route either 2 rag. of killed cells of BCG, or 2 rag. of killed ceils of Myco. 
fortgitum, or physiological saline. The animals were sacrificed 1 day, 3 days, or 6 days after 
TABLE IV 
Activation of Chronic Myco.  fortuitum Infection by Intraperitoneal Injection of Pertussis Vaccine 
or Killed BCG Cells 
Materials injected 
(i.p.) 
Pertussis vaccine~ 
Killed BCG§ 
Saline 
Pertussis vaccine~ 
Killed BCG§ 
Saline 
Time 
tween 
treat- 
ment 
and 
sacri- 
fice 
days 
5 
t~ 
tc 
9 
Numbers of bacterial colonies recovered from 
Liver*  Kidney* 
20  27  600  70C 
13  20  180  60C 
0  1  25  4~ 
1  2  3  28C 
25  600  200C 
0  1  6  60' 
3X 104  2X 105  5X 105  5X  10  s 
X  I04  5X  104  7 X  104  5X  105 
16  1 X  10'  2X 104  6X  104 
3X  104  5X  104  2×  10  s  5X  105 
i×  104  6X104  5×106  -- 
0  20  4 X  104  8×  104 
* Figures to be multiplied by 1000 for whole organ. 
Approximately  10 billion cells, diluted to 0.2 ml. saline. 
§ 2 mg. injected in 0.2 ml. saline. 
receiving the bacterial  suspensions and the numbers of viable cells of Myco. for~itum pres- 
ent in their  organs at the time of sacrifice were determined  by quantitative bacteriological 
techniques.  The results  are  summarized  in Table  V,  which also presents  the  changes  in 
weight of individual animals before sacrifice. 
The results presented in Table V  confirm and extend those of the preceding 
experiment.  In  this  case  again,  intraperitoneal  injection  of  2  rag.  of  killed 
mycobacteria  brought  about  a  rapid  activation  of the  chronic  infection  es- 
tablished  in mice 3  months before with Myco. fortuitum.  As can be seen, ex- 
tensive multiplication of these organisms in the liver and kidneys was apparent 
within 3 days after injection of the killed bacillary bodies. 
Table VI presents the results of a  similar experiment in which a  chronic in- 
fection, established  56 days before by the intravenous injection of 0.02 ml. of 
the atypical mycobacteria P17, was activated by treatment with killed cells of 724  HETEROLOGOUS  SUSCEPTIBILITY  ELICITED  BY  MYCOBACTERIA 
Myco. fortuitum  or BCG.  It  can  be  seen  that  extensive multiplication  of  the 
bacteria in the liver and lungs was evident as early as 3  days after administra- 
TABLE V 
Activation of Chronic Myco. fortuitum Infection by Intraperitoneal Injection of Killed Cells of 
BCG and Myco. fortuitum 
Materials injected 
(i.p.) 
tlyco, fortuitum  2.0 mg. 
~CG  2.0 mg. 
;aline  O. 2 cc. 
~yco. fortuitum  2.0 mg. 
BCG  2.0 rag. 
;aline  O. 2 cc. 
~Iyco. fortuitum  2.0 rag. 
BCG  2.0 rag. 
;aline  0.2 cc. 
Time  Numbers  of bacterial 
Cumulative weight change at  between  colonies  recovered  from  indicated days (d.) after injection  treat- 
ld.  3d. 
+1.1 
--1.5 
--3.1 
--1.6 
--2.3 
--3.5 
--.2 
+.8 
--.9 
gin. per mouse 
-3.6  --4.3 
-2.1  -1.4 
--2.1  --1.8 
--0.5  -3.8 
-2.0  --2.3 
-2.3  --2.5 
0  -0.6 
+0.2  +0.9 
+0.1  +0.5 
ment 
6 d.  and 
sacrifice 
days 
1 
~¢ 
lc 
gC 
3 
~C 
~c 
~c 
6 
gc 
gc 
C¢ 
g¢ 
lc 
gc 
--2.8  --2.8  --3.1 
--2.8  --2.7  --0.8 
--4.2  --5.4  --6.1 
--3.6  --4.2  --3.6 
--1.4  0  +1.0 
--4.1  --4.7  --1.5 
--2.6  --1.6  0 
+.9  +2.1  +4.1 
+.7  +1.0  +1.6 
--0.5  --0.4  --0.6 
+0.7  +0.7  +0.7 
Liver*  Kidney* 
0  3 
0  9X10 ~ 
38  5 X  10. 
0  IX102 
0  4X  I0' 
2  5X10. 
0  9 
0  25 
0  1X10* 
1 X  10  ~  5 X  10~ 
6X10 s  4X108 
5 X  10.  5X  10. 
?  5X  10' 
?  1 X  106 
?  ? 
0  34 
0  1X10 ~ 
0  3XlO 2 
1  X  10'  5  X  10  a 
3 X  108  9 X  10' 
4  X  10  a  1 X  10. 
5 X  10'  1 X  10  ~ 
0  50 
1  2X10. 
70  1 X  104 
0  0 
0  6 
0  4X  10  ~ 
1  8X10 a 
* Figures to be multiplied by 1000 for whole organ. 
tion of the killed mycobacterial cells. In preliminary experiments with chronic 
staphylococcal  infections--not  reported  here---clear  evidence of activation  of 
the  infectious  process  in  the  liver and  kidneys  was  observed  24  hours  after 
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The  findings in  the  liver are of  special interest  since Myco. fortuitum  and 
Staph.  aureus  are always rapidly eliminated from  this organ in normal  mice, 
TABLE VI 
Activation of Chronic MycobacteriaI (PIT) Infection by Iraraperitoneal Injection of Killed Cells 
of BCG and Myco. fortuitum 
Materials injected 
(i.p.) 
Myco.fortuitum  2.0mg. 
BCG  2.0 rag. 
Saline  O. 2 cc. 
Myco. fortuitum  2.0 mg. 
BCG  2.0 rag. 
Saline  0.2 cc. 
Myco. fort~um  2.0 nag. 
BCG  2.0 rag. 
Saline  0.2 cc. 
ld. 
Cumulative weight change  Numbers of bacterial 
at indicated days (d.)  colonies recovered from 
after injection 
3 d.  6 d.  I0 d.  Liver*  Lungs* 
-1.7  -2.4 
--1.3  --1.0 
--1.6  --0.7 
--1.0  --0.6 
--0.4  41.0 
-3.0  -1.3 
+0.2  +1.5 
+0.6  41.5 
41.0  41.6 
--2.2  --2.6  --1.4 
--3.0  --0.6  --1.0 
40.7  41.6  43.9 
--2.6  --1.4  --0.1 
--2.7  --1.7  --2.1 
I--2.9  --1.8  40.2 
i41.3  42.5  42.5 
0  40.2  0 
0  41.4  41.5 
-1.0  --0.8  +1.0  +1.7 
-0.9  +0.2  +1.5  +1.9 
-3.9  -2.1  --2.8  --1.~ 
-2.2  -0.5  -I-1.3  -t-2.2 
-2.8  --2,9  --1.9  --0.,~ 
0  -0.4  -0.3  +0.7 
+1.3  +1.2  +1.1  41.12 
+0.6  40.7  --0.2  --0.3 
+0.2  W1.9  41.9  42.~ 
Time 
between 
treatment 
and 
sacrifice 
days 
3 
¢¢ 
¢¢ 
¢¢ 
4~ 
¢¢ 
¢¢ 
6 
¢¢ 
¢¢ 
10 
4¢ 
4¢ 
4¢ 
¢¢ 
1 X  1@  16 
8  X  10  ~  20 
1 X  105  1 X  105 
6  3 
13  0 
23  5 
0  0 
0  0 
0  0 
1X 104  8 
0  0 
3 X  l0  s  8 
1  2 
25  1 X  104 
4O  1 
0  0 
0  0 
0  0 
1 X  10  5  5 
I X  10  6  i X  I0  4 
1X 104  0 
1  0 
26  0 
0  0 
0  0 
0  0 
0  0 
* Figures to be multiplied by 1000 for whole organ. 
whereas they multiplied rapidly in the treated animals. It is worthy of men- 
tion, furthermore,  that the livers of several of the animals which had received 
the killed mycobacteria yielded on numerous occasions large numbers of colo- 
nies of organisms belonging to species other than  the bacteria injected. This 
fact suggests that  the physiological disturbances resulting from  the injection 
of the killed mycobacteria interfered with the clearing power of the liver cells 726  HETEROLOGOUS  SUSCEPTIBILITY ELICITED  BY  ~YCOBACTERIA 
and thus allowed the colonization in this organ of organisms derived from the 
intestinal tract. 
SUMMARY 
Injection of certain cellular constituents of mycobacteria into mice simul- 
taneously with, or shortly after, infection  with Staph.  aureus or with Myco. 
fortuitum, markedly shortened the life of the infected animals. This infection- 
enhancing  effect could be achieved  by injecting the cellular  constituents by 
either the intravenous,  the intraperitoneal,  or the subcutaneous route. 
Suspensions of killed mycobacteria were injected into mice which had been 
infected several months before with small doses of various bacterial  pathogens 
and which still  harbored small numbers of living organisms in their organs. 
Under these  conditions,  a marked increase in the numbers of living bacteria 
in the organs  of the treated mice could be detected within a  very few days 
after treatment with the mycobacterial products, and a certain percentage  of 
the animals died rapidly. 
One of the first and most constant manifestations of the change in the in- 
fectious process from the chronic to the acute state was the appearance  of a 
large  microbial  population in  the liver.  This happened  even  though Staph. 
aureus and Myco. fortuitum are rapidly cleared from the liver of normal mice. 
In addition to killed cells of BCG and of Myco. fortuitum, pertussis vaccine 
and the purified lipopolysaccharide  (endotoxin)  of Gram-negative  bacilli also 
proved capable of converting  chronic bacterial infections into acute infectious 
processes. 
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